Outlook Therapeutics, Inc. Debt Conversion, Original Debt, Amount
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2026-08-18
- Outlook Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2026-06-30 was $11.17M.
- Outlook Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2026-03-31 was $6.91M.
- Outlook Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2025-12-31 was $30.74K.
- Outlook Therapeutics, Inc. debt conversion, original debt, amount for the quarter ending 2025-09-30 was $2.50M, a 28.57% decline year-over-year.
- Outlook Therapeutics, Inc. debt conversion, original debt, amount for fiscal 2025 was $2.52M, a 77.56% decline from fiscal 2024.
- Outlook Therapeutics, Inc. debt conversion, original debt, amount for fiscal 2024 was $11.25M, a 44900.00% increase from fiscal 2023.
- Outlook Therapeutics, Inc. debt conversion, original debt, amount for fiscal 2023 was $25.00K.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-18 | $18.08M derived: sum of 2 quarters · filed 2026-08-18 | $18.11M 10-Q · filed 2026-08-18 | $20.61M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-03-31 | $6.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $6.94M 10-Q · filed 2026-05-15 | $9.44M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $30.74K 10-Q · filed 2026-02-17 | $2.53M derived: sum of 2 quarters · filed 2026-02-17 | ||
| 2025-09-30 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | $2.52M 10-K · filed 2025-12-19 | ||
| 2025-06-30 | $25.00K 10-Q · filed 2026-08-18 | |||
| 2024-09-30 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | $8.25M derived: sum of 2 quarters · filed 2025-12-19 | $11.25M 10-K · filed 2025-12-19 | |
| 2024-06-30 | $4.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $7.75M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $3.00M 10-Q · filed 2025-05-15 | |||
| 2023-09-30 | $25.00K 10-K · filed 2024-12-27 |